Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma
- PMID: 15875183
- DOI: 10.1007/s00277-005-1051-3
Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma
Abstract
This study aimed to assess the differences in the cellular composition of the inflammatory reactive background around tumoral cells of classical Hodgkin's lymphomas (cHL) inside and outside the HIV settings. This retrospective study evaluates the infiltrating T lymphocytes (CD4 and CD8), natural killer cells (CD57+ cells), and more especially cytotoxic cells [granzyme B (GrB) and TIA-1+ cells] in the background of 99 EBV+ cHL. Sections from paraffin-embedded tumor samples from nine HIV-infected cHL patients were immunostained, using standard immunohistochemical protocols and were compared to a control group of 90 HIV-noninfected cHL patients. Our clinical and histological data indicate that HIV-infected cHL patients present a higher frequency of mixed cellularity (MC) histological subtypes, more advanced disease stages, a poor response to treatment, and a poor overall survival compared to control patients. In controls, CD4/CD8 and GrB/TIA-1 ratios were determined as 2:1 and 1:2, respectively. The inflammatory infiltrate of HIV-infected patients had a significant reduction of CD4+ T lymphocytes (CD4/CD8 ratio 1:23), a decrease in infiltrating GrB+ cells (activated cytotoxic cells) and an increase in infiltrating TIA+ T cells (mainly nonactivated cytotoxic cells) in these patients (GrB/TIA-1 ratio 1:12). In conclusion, this study highlights an important intratumoral loss of CD4+ T cells (striking inversion in the CD4/CD8 ratio) and a decrease in intratumoral activated cytotoxic T lymphocytes in HIV-associated cHL patients. Further studies are required to confirm these results and to determine the role of these findings on the antitumoral immune response observed in HIV-associated cHL.
Similar articles
-
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.Clin Cancer Res. 2005 Feb 15;11(4):1467-73. doi: 10.1158/1078-0432.CCR-04-1869. Clin Cancer Res. 2005. PMID: 15746048
-
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.Anticancer Res. 1999 Mar-Apr;19(2A):1209-16. Anticancer Res. 1999. PMID: 10368677
-
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.Am J Clin Pathol. 2007 Dec;128(6):958-65. doi: 10.1309/NB3947K383DJ0LQ2. Am J Clin Pathol. 2007. PMID: 18024321
-
Disruption of the gamma c cytokine network in T cells during HIV infection.Cytokine. 2008 Jul;43(1):1-14. doi: 10.1016/j.cyto.2008.03.001. Epub 2008 Apr 15. Cytokine. 2008. PMID: 18417356 Review.
-
Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.Am J Surg Pathol. 1998 Oct;22(10):1184-91. doi: 10.1097/00000478-199810000-00003. Am J Surg Pathol. 1998. PMID: 9777980 Review.
Cited by
-
The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good.Cancers (Basel). 2022 Mar 7;14(5):1360. doi: 10.3390/cancers14051360. Cancers (Basel). 2022. PMID: 35267668 Free PMC article. Review.
-
High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).Hum Vaccin Immunother. 2013 May;9(5):957-68. doi: 10.4161/hv.23774. Epub 2013 Jan 31. Hum Vaccin Immunother. 2013. PMID: 23370281 Free PMC article.
-
Automated quantification of nuclear immunohistochemical markers with different complexity.Histochem Cell Biol. 2008 Mar;129(3):379-87. doi: 10.1007/s00418-007-0368-5. Epub 2008 Jan 3. Histochem Cell Biol. 2008. PMID: 18172664
-
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.Pathology. 2021 Aug;53(5):628-634. doi: 10.1016/j.pathol.2020.11.004. Epub 2021 Feb 6. Pathology. 2021. PMID: 33558066 Free PMC article.
-
Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.J Biomed Biotechnol. 2010;2010:846872. doi: 10.1155/2010/846872. Epub 2010 Aug 12. J Biomed Biotechnol. 2010. PMID: 20814546 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous